NO991693L - Compounds and methods for the diagnosis of tuberculosis - Google Patents

Compounds and methods for the diagnosis of tuberculosis

Info

Publication number
NO991693L
NO991693L NO991693A NO991693A NO991693L NO 991693 L NO991693 L NO 991693L NO 991693 A NO991693 A NO 991693A NO 991693 A NO991693 A NO 991693A NO 991693 L NO991693 L NO 991693L
Authority
NO
Norway
Prior art keywords
tuberculosis
compounds
polypeptides
methods
diagnosis
Prior art date
Application number
NO991693A
Other languages
Norwegian (no)
Other versions
NO991693D0 (en
Inventor
Steven G Reed
Yasir A W Skeiky
Davin C Dillon
Antonio Campos-Neto
Raymond Houghton
Thomas S Vedvick
Daniel R Twardzik
Michael J Lodes
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO991693D0 publication Critical patent/NO991693D0/en
Publication of NO991693L publication Critical patent/NO991693L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Forbindelser og metoder for diagnostisering av tuberkulose er beskrevet. Forbindelsene tilveiebragt inkluderer polypeptider som inneholder minst en antigendel eller en eller flere M. tuberkuloseproteiner, og DNA-sekvenser som koder for slike polypeptider. Diagnostiske kit som inneholder slike polypeptider eller DNA-sekvenser og en passende deteksjonsreagens kan bli brukt for deteksjon av M. tuberkuloseinfeksjon i pasienter og biologiske prerver. Antistoffer rettet mot slike polypeptider er også tilveiebragt.Compounds and methods for diagnosing tuberculosis are described. The compounds provided include polypeptides containing at least one antigen moiety or one or more M. tuberculosis proteins, and DNA sequences encoding such polypeptides. Diagnostic kits containing such polypeptides or DNA sequences and a suitable detection reagent may be used for the detection of M. tuberculosis infection in patients and biological samples. Antibodies directed against such polypeptides are also provided.

NO991693A 1996-10-11 1999-04-09 Compounds and methods for the diagnosis of tuberculosis NO991693L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72962296A 1996-10-11 1996-10-11
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis
PCT/US1997/018214 WO1998016645A2 (en) 1996-10-11 1997-10-07 Compounds and methods for diagnosis of tuberculosis

Publications (2)

Publication Number Publication Date
NO991693D0 NO991693D0 (en) 1999-04-09
NO991693L true NO991693L (en) 1999-06-09

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991693A NO991693L (en) 1996-10-11 1999-04-09 Compounds and methods for the diagnosis of tuberculosis

Country Status (11)

Country Link
EP (1) EP0934415A2 (en)
JP (1) JP2001500383A (en)
AU (1) AU4750597A (en)
BR (1) BR9712298A (en)
CA (1) CA2268036A1 (en)
CZ (1) CZ126699A3 (en)
IL (2) IL129389A0 (en)
NO (1) NO991693L (en)
PL (1) PL333304A1 (en)
TR (1) TR199901569T2 (en)
WO (1) WO1998016645A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US6436409B1 (en) * 1997-07-16 2002-08-20 Institut Pasteur Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
DE60042078D1 (en) 1999-05-04 2009-06-04 Univ New Jersey Med BY MYCOBACTERIUM TUBERCULOSIS AND NOT BY BCG EXPRESSED PROTEINS AND ITS USE AS DIAGNOSTIC REAGENTS AND VACCINES
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
DK1517913T3 (en) * 1999-10-07 2007-06-18 Corixa Corp A Mycobacterium tuberculosis coding sequence for expression of heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2001062893A2 (en) 2000-02-25 2001-08-30 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
DK1542732T3 (en) 2000-06-20 2009-12-14 Corixa Corp Fusion proteins of Mycobacterium tuberculosis
WO2002004018A2 (en) * 2000-07-10 2002-01-17 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
WO2003000721A2 (en) 2001-06-22 2003-01-03 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
US7393540B2 (en) 2001-07-04 2008-07-01 Health Protection Agency Mycobacterial antigens expressed during latency
CN100351374C (en) * 2001-07-25 2007-11-28 东曹株式会社 Oligonucleotides for detecting tubercle bacillus and method therefor
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
AU2003213118A1 (en) 2002-02-15 2003-09-09 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
EP1812580B1 (en) 2004-11-16 2014-12-17 Crucell Holland B.V. Multivalent vaccines comprising recombinant viral vectors
PT1877426E (en) 2005-04-29 2012-05-02 Glaxosmithkline Biolog Sa Method for preventing or treating m tuberculosis infection
AU2006272567B2 (en) * 2005-07-26 2011-10-06 Rutgers, The State University Of New Jersey Antibody profiles characteristic of tuberculosis state
CN100999550B (en) * 2006-01-10 2010-10-06 中国人民解放军第三○九医院 Tubercle branch bacillus fusion protein and application thereof
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
EP2368568A1 (en) 2006-11-01 2011-09-28 Immport Therapeutics, INC. Compositions and methods for immunodominant antigens
CA2786969C (en) 2010-01-27 2018-07-24 Glaxosmithkline Biologicals S.A. Modified tuberculosis antigens
CN115746092B (en) * 2022-08-12 2024-08-13 齐鲁工业大学 Spirulina platensis phycocyanin active peptide with antioxidant and anti-aging activities and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
FR2677365B1 (en) * 1991-06-07 1995-08-04 Pasteur Institut MYCOBACTERIUM PROTEINS AND APPLICATIONS.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79793D0 (en) * 1993-07-02 1993-07-02 Statens Seruminstitut DIAGNOSTIC TEST
DK79893D0 (en) * 1993-07-02 1993-07-02 Statens Seruminstitut NEW VACCINE
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
TR200806258T2 (en) * 1995-09-01 2008-10-21 Corixa Corporation Compounds and methods for the diagnosis and prevention of tuberculosis by immunotherapy
EP0850305B1 (en) * 1995-09-01 2006-04-26 Corixa Corporation Compounds and methods for diagnosis of tuberculosis

Also Published As

Publication number Publication date
WO1998016645A2 (en) 1998-04-23
WO1998016645A3 (en) 1998-08-06
PL333304A1 (en) 1999-11-22
AU4750597A (en) 1998-05-11
CZ126699A3 (en) 1999-09-15
NO991693D0 (en) 1999-04-09
EP0934415A2 (en) 1999-08-11
JP2001500383A (en) 2001-01-16
IL129389A0 (en) 2000-02-17
TR199901569T2 (en) 2000-12-21
IL121936A0 (en) 1998-03-10
BR9712298A (en) 2000-10-24
CA2268036A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
NO995690L (en) Compounds for the diagnosis of tuberculosis and methods for their use
NO991693L (en) Compounds and methods for the diagnosis of tuberculosis
MX9801687A (en) Compounds and methods for diagnosis of tuberculosis.
NO20012812D0 (en) Compounds and Methods for the Treatment and Diagnosis of Chlamydia Infection
DK1307564T3 (en) Compounds and Methods for Treating and Diagnosing Chlamydia Infection
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
NZ518917A (en) Compounds and methods for treatment and diagnosis of chlamydial infection
WO1998042740A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
EP2192128A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
AU7312801A (en) Compositions and methods for the diagnosis and treatment of herpes simplex virusinfection
SE8701905L (en) PROCEDURAL AND KIT FOR DIAGNOSIS OF IGA NEPHROPATI
SE8900721D0 (en) METHODS FOR DETECTION OF ANTIBODIES TO
EP1712629A3 (en) Compounds and methods for diagnosis of tuberculosis
TH84254A (en) Compounds and methods for the diagnosis of tuberculosis
TH84254B (en) Compounds and methods for the diagnosis of tuberculosis
AR013326A1 (en) ISOLATED POLYPEPTIDE, DNA MOLECULA, RECOMBINANT EXPRESSION VECTOR, GUEST CELL, METHOD FOR DETECTING THE INFECTION OF M. TUBERCULOSIS IN A BIOLOGICAL SAMPLE, DIAGNOSTIC EQUIPMENT, MONOCLONAL ANTIBODY, AND ANTICUERPO,

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application